Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections

Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity

(2012) Dimitra Mitsani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring

(2012) Michael J. Dolton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal Infections

(2012) Andres Pascual et al.   CLINICAL INFECTIOUS DISEASES

Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients

(2012) S. Pieper et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis

(2012) Yukihiro Hamada et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience

(2012) Zdenek Racil et al.   MYCOSES

Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients

(2011) Peter F. Troke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole

(2011) Stefania Cocchi et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers

(2011) SeungHwan Lee et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacogenomics of the triazole antifungal agent voriconazole

(2011) Gerd Mikus et al.   PHARMACOGENOMICS

A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients

(2011) Lindsey R Lombardi et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Bioavailability and Population Pharmacokinetics of Voriconazole in Lung Transplant Recipients

(2010) K. Han et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients

(2010) Maud Berge et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring

(2010) Céline Eiden et al.   XENOBIOTICA

Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype

(2009) Ina Scholz et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Vancomycin Dosage Optimization in Patients with Malignant Haematological Disease by Pharmacokinetic/Pharmacodynamic Analysis

(2009) Maria del Mar Fernández de Gatta et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetics and drug metabolism in the elderly

(2009) Ulrich Klotz   DRUG METABOLISM REVIEWS

Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies

(2008) M. O. Karlsson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetic–pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies

(2008) K. Nomura et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

CYP2C19Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole

(2008) Johanna Weiss et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES